Regulatory networks of post-translational modifications in diabetic kidney disease: from pathogenic mechanisms to therapeutic frontiers - Takeaways - MDSpire

Regulatory networks of post-translational modifications in diabetic kidney disease: from pathogenic mechanisms to therapeutic frontiers

  • By

  • Qing Jiang

  • Deqi Meng

  • Shenglong Zhu

  • Wei Tang

  • Siyuan Cui

  • June 23, 2026

  • 0 min

Share

  • 1

    Diabetic kidney disease (DKD) affects 30-40% of diabetic patients and can progress to end-stage renal disease without intervention.

  • 2

    Post-translational modifications (PTMs) regulate protein function and stability, playing a crucial role in the pathogenesis of DKD.

  • 3

    Dysregulated PTM networks in DKD link metabolic disturbances to renal injury, influencing pathways like Wnt/β-catenin and TGF-β/Smad.

  • 4

    Aberrant phosphorylation patterns in insulin signaling and MAPK pathways contribute to insulin resistance and renal injury in DKD.

  • 5

    Targeting PTM-modifying enzymes may represent a novel therapeutic strategy for halting the progression of diabetic kidney disease.

Original Source(s)

Regulatory networks of post-translational modifications in diabetic kidney disease: from pathogenic mechanisms to therapeutic frontiers

  • by Qing Jiang, Deqi Meng, Shenglong Zhu, Wei Tang, Siyuan Cui

  • June 23, 2026

Related Content

The metabolic syndrome-cancer axis: global research trends and clinical landscapes

GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection

Predicting heart failure in asymptomatic diabetes: derivation and internal validation of a clinical prediction model for early detection of diabetic cardiomyopathy